| BIOMARIN Biomarin Pharmaceutical Inc. 1595055 30 Oct 2013 | Protected: Registered/protected | Pharmaceutical preparations for use in enzyme therapy; pharmaceutical ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; assays, screening kits, devices, and equipment for medical analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease markers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions | |
| BIOMARIN Biomarin Pharmaceutical Inc. 1101916 6 Mar 2006 | | Assays, screening kits, for scientific analysis; assays, screening kit... Class 001 Class 001 Chemical Products Assays, screening kits, for scientific analysis; assays, screening kits for measurement of disease markers for scientific purposes Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in enzyme therapy; pharmaceutical preparations for use in treatment of genetic disorders; pharmaceutical preparations for use in burn and wound debridement or cleaning; pharmaceuticals for treatment of inflammation, infectious diseases and cardiovascular diseases; assays, screening kits, devices, and equipment for medical analysis and diagnosis of disorders and physiological processes; assays, screening kits, devices, and equipment for measurement of disease makers for medical purposes; carbohydrate inhibiting enzymes for use in disease treatment; fungal lytic enzymes for the treatment of fungal infections; pharmaceuticals for treatment of lysosomal storage diseases; pharmaceuticals for treatment of mucopolysaccharidoses; pharmaceuticals for treatment of carbohydrate-inhibiting enzyme disorders; proteins and enzymes for the production, purification and isolation of biologics for use in the treatment of medical conditions; biologics produced by recombinant DNA technology for use in the treatment of pathological medical conditions; assays, screening kits, devices and equipment for diagnosis of disorders and physiological processes | |
